Using laser technology to improve anal cancer screening for HIV-positive patients
Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients
['FUNDING_R21'] · UNIVERSITY OF HAWAII AT MANOA · NIH-9856763
This study is testing a new, gentle way to check for anal dysplasia in people with HIV, using a special laser technique that could make screenings easier and more comfortable than the usual methods.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF HAWAII AT MANOA (nih funded) |
| Locations | 1 site (HONOLULU, UNITED STATES) |
| Trial ID | NIH-9856763 on ClinicalTrials.gov |
What this research studies
This research investigates a new method called Raman-enhanced spectroscopy (RESpect) to screen for anal dysplasia in HIV-positive individuals, who are at a significantly higher risk for anal cancer. The study aims to develop a less invasive alternative to current screening methods, which often involve uncomfortable biopsies. By analyzing the chemical composition of cells and tissues with laser technology, the research seeks to provide a more accurate and patient-friendly screening option. This innovative approach could lead to better prevention strategies for anal cancer in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are HIV-positive individuals, particularly men, who are at high risk for anal dysplasia and cancer.
Not a fit: Patients who are not HIV-positive or those who do not have a history of anal dysplasia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective and less invasive screening method for anal cancer, improving early detection and patient outcomes.
How similar studies have performed: While the use of Raman-enhanced spectroscopy is a novel approach in this context, similar technologies have shown promise in other areas of cancer detection.
Where this research is happening
HONOLULU, UNITED STATES
- UNIVERSITY OF HAWAII AT MANOA — HONOLULU, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AGSALDA-GARCIA, MELISSA ANNE — UNIVERSITY OF HAWAII AT MANOA
- Study coordinator: AGSALDA-GARCIA, MELISSA ANNE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer